Stephen G. Davies

Stephen Graham Davies (born 24 February 1950) is a British chemist[2] and the Waynflete Professor of Chemistry at the University of Oxford.

Steve Davies
Stephen Graham Davies

(1950-02-24) 24 February 1950 (age 72)
Alma materUniversity of Oxford (BA, DPhil)
(m. 1973⁠–⁠2000)
AwardsHickinbottom Award (1984)
Scientific career
InstitutionsUniversity of Oxford
Centre national de la recherche scientifique
ThesisStudies on epoxides (1975)
Doctoral advisorGordon H. Whitham
Doctoral studentsSue Gibson[1]


Davies obtained his Bachelor of Arts degree in 1973 from New College, Oxford, and his Doctor of Philosophy in 1975[3] under the supervision of Gordon H. Whitham.

Career and researchEdit

After his PhD, Davies subsequently held an ICI Postdoctoral Fellowship working with Malcolm Green (1975-1977) and a NATO Fellowship working with Derek Barton (1977-1978) before joining the Centre national de la recherche scientifique (CNRS) at Gif-sur-Yvette as Attaché de Recherche working with Hugh Felkin.[4]

In 1980 he returned to Oxford to take up a University Lectureship in Chemistry. Whilst remaining an active academic, in 1991 he founded Oxford Asymmetry Ltd (an asymmetric synthesis company) as sole investor.[5] He also founded Oxford Diversity Ltd (a combinatorial chemistry company).[6] These two companies were combined to form Oxford Asymmetry International Plc in 1999 which was sold to Evotec in 2000, valued at £316m.[7][8] In 2003 he founded VASTox (Value Added Screening Technology Oxford) a zebrafish screening company. It floated on AIM in 2004 and has since acquired Dainolabs (zebrafish) and Dextra (a carbohydrate chemistry company) as well as the assets of MNL Pharma.[6] VASTox then changed its name to Summit.[9] In 2009 the zebrafish screening operations was acquired by Evotec for £0.5 Million.[10] In 1996, he became Professor of Chemistry[5] and in 2006, Waynflete Professor of Chemistry.

Davies is founder and editor-in-chief for Tetrahedron: Asymmetry.

Davies along with Malcolm Green and Michael Mingos have compiled a set of rules that summarize where nucleophilic additions will occur on pi ligands.


Personal lifeEdit

Davies is the son of Gordon W. J. Davies and June M. Murphy.[citation needed] In 1973 he married Kay E. Partridge who was to become a foremost human geneticist. They have one son.[2]


  1. ^ Gibson, Susan E. (1984). Transition metal promoted oxidation and reduction reactions. (DPhil thesis). University of Oxford. OCLC 499841275. EThOS
  2. ^ a b c d Sleeman, Elizabeth (2003). The International Who's Who 2004. Routledge. p. 398. ISBN 1-85743-217-7.
  3. ^ Davies, Stephen Graham (1975). Studies on Epoxides. (PhD thesis). University of Oxford. EThOS
  4. ^ "About Steve Davies". Archived from the original on 31 May 2010. Retrieved 24 June 2012.
  5. ^ a b "Interview with Steve Davies" (PDF). Saïd Business School. Retrieved 24 June 2012.[permanent dead link]
  6. ^ a b "Chemistry's millionaire" (PDF). Royal Society of Chemistry. Retrieved 24 June 2012.
  7. ^ Griffiths, Katherine (1 August 2000). "Oxford Asymmetry agrees to German merger worth £316m". The Independent. Retrieved 17 June 2009.
  8. ^ "Success Stories". Oxford Investment Opportunity network. Archived from the original on 7 March 2013. Retrieved 24 June 2012.
  9. ^ "Board of Directors". Archived from the original on 6 July 2012. Retrieved 24 June 2012.
  10. ^ "Evotec Acquires Zebrafish Screening Operations of Summit Corporation". Archived from the original on 28 December 2010. Retrieved 24 June 2012.
  11. ^ "Steve G Davies". Oxford Cardiovascular Science. Retrieved 24 June 2012.
  12. ^ "Organometallic Chemistry Award Winners". RSC. Retrieved 17 June 2009.
  13. ^ "Bader Award Winners". RSC. Retrieved 17 June 2009.
  14. ^ "Tilden Lectureships Winners". RSC. Retrieved 17 June 2009.
  15. ^ a b "Stephen Davies: Ececutive Profile & Biography". business week. Retrieved 24 June 2012.
  16. ^ "Perkin Prize for Organic Chemistry 2011 Winner". Royal Society of Chemistry. Retrieved 25 November 2014.